[Essential thrombocythemia].
D000925:Anticoagulants / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects; D010983:Plateletpheresis; D011379:Prognosis; D013920:Thrombocythemia, Essential / Q000473:pathology / Q000628:therapy
D000925:Anticoagulants; D000970:Antineoplastic Agents
Trombocitemia esencial.